Mamon, H. J., Niedzwiecki, D., Hollis, D. R., Tan, B., Smith, J., Blackstock, A. W., … Fuchs, C. S. (2005). Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma. In International Journal of Radiation Oncology*Biology*Physics (Vol. 63, pp. S13–S13). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2005.07.028

Mamon, H. J., D. Niedzwiecki, D. R. Hollis, B. Tan, J. Smith, A. W. Blackstock, J. E. Tepper, R. M. Goldberg, R. J. Mayer, and C. S. Fuchs. “Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma.” In International Journal of Radiation Oncology*Biology*Physics, 63:S13–S13. Elsevier BV, 2005. https://doi.org/10.1016/j.ijrobp.2005.07.028.

Mamon HJ, Niedzwiecki D, Hollis DR, Tan B, Smith J, Blackstock AW, et al. Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2005. p. S13–S13.

Mamon, H. J., et al. “Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma.” International Journal of Radiation Oncology*Biology*Physics, vol. 63, Elsevier BV, 2005, pp. S13–S13. Crossref, doi:10.1016/j.ijrobp.2005.07.028.

Mamon HJ, Niedzwiecki D, Hollis DR, Tan B, Smith J, Blackstock AW, Tepper JE, Goldberg RM, Mayer RJ, Fuchs CS. Preliminary Analysis of Cancer and Leukemia Group B (CALGB) 80003: A Phase II Trial of Gemcitabine, 5-Fluorouracil (5FU), and Radiation Therapy (RT) in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2005. p. S13–S13.